Details for New Drug Application (NDA): 206049
✉ Email this page to a colleague
The generic ingredient in METHYLPHENIDATE HYDROCHLORIDE is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Summary for 206049
Tradename: | METHYLPHENIDATE HYDROCHLORIDE |
Applicant: | Actavis Labs Fl Inc |
Ingredient: | methylphenidate hydrochloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | FOR SUSPENSION, EXTENDED RELEASE;ORAL | Strength | 5MG/ML | ||||
Approval Date: | May 17, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription